Pharmacogenomic Profiling of Cisplatin-Resistant and -Sensitive Human Osteosarcoma Cell Lines by Multimodal Targeted Next Generation Sequencing

Cisplatin (CDDP) is a drug for high-grade osteosarcoma (HGOS) treatment. Several germline pharmacogenetic studies have revealed associations between single nucleotide polymorphisms (SNPs) and CDDP-based therapy response or CDDP-related toxicity in patients with HGOS. Whether these variants could pla...

Descripción completa

Detalles Bibliográficos
Autores principales: Hattinger, Claudia Maria, Casotti, Chiara, Patrizio, Maria Pia, Luppi, Silvia, Fantoni, Leonardo, Scotlandi, Katia, Ibrahim, Toni, Serra, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570120/
https://www.ncbi.nlm.nih.gov/pubmed/36233089
http://dx.doi.org/10.3390/ijms231911787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570120/
https://www.ncbi.nlm.nih.gov/pubmed/36233089
http://dx.doi.org/10.3390/ijms231911787

Ejemplares similares